GoodRx Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of GoodRx Holdings using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $0.08 | $0.09 | -11.1 % |
Jun 2024 | 2024-08-08 | $0.08 | $0.09 | -11.1 % |
Mar 2024 | 2024-05-09 | $0.08 | $0.07 | 14.3 % |
Dec 2023 | 2024-02-29 | $0.08 | $0.07 | 14.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $195.25M | $195.65M | -0.20 % |
Jun 2024 | 2024-08-08 | $200.61M | $200.51M | 0.05 % |
Mar 2024 | 2024-05-09 | $197.88M | $196.01M | 0.95 % |
Dec 2023 | 2024-02-29 | $196.64M | $195.83M | 0.42 % |
GoodRx Holdings (GDRX) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $0.08, which missed the estimate of $0.09.
The Actual Revenue was $195.3M, which missed the estimate of $195.7M.
Browse earnings estimates, EPS, and revenue on all stocks.